| Section | Title | Authors | Address |
|---|
|
| Genes | ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Viguié F | http://atlasgeneticsoncology.org/Genes/PGY1ID105.html |
| Genes | ABCC1 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) | Viguié F | http://atlasgeneticsoncology.org/Genes/MRPID106.html |
| Genes | APC (adenomatous polyposis coli) | Hamelin P | http://atlasgeneticsoncology.org/Genes/APCID118.html |
| Genes | ATM (ataxia telangiectasia mutated) | Huret JL | http://atlasgeneticsoncology.org/Genes/ATMID123.html |
| Genes | BCL2 (B-Cell Leukemia/Lymphoma 2) | Huret JL | http://atlasgeneticsoncology.org/Genes/BCL2ID49.html |
| Genes | BCL6 (B-Cell Lymphoma 6) | Kerckaert JP | http://atlasgeneticsoncology.org/Genes/BCL6ID20.html |
| Genes | BLM (Bloom) | Huret JL | http://atlasgeneticsoncology.org/Genes/BLMID109.html |
| Genes | CCND1 (B-cell leukemia/lymphoma 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/BCL1ID36.html |
| Genes | CDKN1B (cyclin-dependent kinase inhibitor 1 B) | Bilhou-Nabera C | http://atlasgeneticsoncology.org/Genes/CDKN1BID116.html |
| Genes | DDX10 DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 | Huret JL | http://atlasgeneticsoncology.org/Genes/DDX10ID35.html |
| Genes | DEK (DEK proto-oncogene) | Huret JL | http://atlasgeneticsoncology.org/Genes/DEKID23.html |
| Genes | EPS15 (epidermal growth factor receptor pathway substrate 15) | Bernard O | http://atlasgeneticsoncology.org/Genes/AF1pID11.html |
| Genes | EWSR1 (Ewing sarcoma breakpoint region 1) | Mugneret F | http://atlasgeneticsoncology.org/Genes/EWSR1ID85.html |
| Genes | FANCA (Fanconi anemia, complementation group A) | Huret JL | http://atlasgeneticsoncology.org/Genes/FA1ID102.html |
| Genes | FANCC (Fanconi anaemia complementation group C) | Huret JL | http://atlasgeneticsoncology.org/Genes/FACCID101.html |
| Genes | FANCD2 (Fanconi anemia, complementation group D2) | Huret JL | http://atlasgeneticsoncology.org/Genes/FADID103.html |
| Genes | FGFR1 (Fibroblast Growth Factor Receptor 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/FGFR1ID113.html |
| Genes | FGFR3 (Fibroblast Growth Factor Receptor 3) | Bonaventure J | http://atlasgeneticsoncology.org/Genes/FGFRID99.html |
| Genes | FOXO3 (forkhead box O3A) | Bernard O | http://atlasgeneticsoncology.org/Genes/AF6q21ID125.html |
| Genes | FOXO4 (myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 7) | Bernard O | http://atlasgeneticsoncology.org/Genes/AFX1ID57.html |
| Genes | HIP1 (Huntingtin interactin protein 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/HIP1ID138.html |
| Genes | HOXA9 (homeobox A9) | Huret JL | http://atlasgeneticsoncology.org/Genes/HOXA9ID61.html |
| Genes | JAK2 (janus kinase 2) | Huret JL | http://atlasgeneticsoncology.org/Genes/JAKID98.html |
| Genes | KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) | Larizza L, Beghini A | http://atlasgeneticsoncology.org/Genes/KITID127.html |
| Genes | KITLG (KIT ligand) | Beghini A | http://atlasgeneticsoncology.org/Genes/MGFID142.html |
| Genes | LCP1 (lymphocyte cytosolic protein1) | Galiègue-Zouitina, S | http://atlasgeneticsoncology.org/Genes/LCP1ID95.html |
| Genes | LMO2 (LIM domain only 2 (rhombotin-like 1)) | Bilhou-Nabera C | http://atlasgeneticsoncology.org/Genes/RBTN2ID34.html |
| Genes | MLLT11 (ALL1 fused gene from chromosome 1q) | Bernard O | http://atlasgeneticsoncology.org/Genes/AF1qID12.html |
| Genes | MTCP1 (Mature T Cell Proliferation 1) | Stern MH | http://atlasgeneticsoncology.org/Genes/MTCP1ID89.html |
| Genes | MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) | Huret JL | http://atlasgeneticsoncology.org/Genes/NMYCID112.html |
| Genes | NBN (Nijmegen breakage syndrome 1) | Huret JL | http://atlasgeneticsoncology.org/Genes/NBS1ID160.html |
| Genes | NF2 (neurofibromatosis type 2) | Huret JL | http://atlasgeneticsoncology.org/Genes/NF2ID117.html |
| Genes | NUP214 (nucleoporin 214kDa) | Huret JL | http://atlasgeneticsoncology.org/Genes/CANID29.html |
| Genes | NUP98 (nucleoporin 98 kDa) | Huret JL | http://atlasgeneticsoncology.org/Genes/NUPID98.html |
| Genes | NUP98 (nucleoporin 98 kDa) | Huret JL | http://atlasgeneticsoncology.org/Genes/NUPID98.html |
| Genes | PICALM (clathrin assembly lymphoid myeloid leukemia gene) | Huret JL | http://atlasgeneticsoncology.org/Genes/CALMID64.html |
| Genes | POU2AF1 (POU domain, class 2, associating factor 1) | Galiègue-Zouitina, S | http://atlasgeneticsoncology.org/Genes/OBFID94.html |
| Genes | RHOH (Ras homolog gene family, member H) | Galiègue-Zouitina, S | http://atlasgeneticsoncology.org/Genes/RHOHID93.html |
| Genes | TAL1 (T-cell acute leukemia 1) | Huret JL, Labastie MC | http://atlasgeneticsoncology.org/Genes/TAL1ID15.html |
| Genes | TCL1A (T-cell leukemia/lymphoma 1A) | Stern MH | http://atlasgeneticsoncology.org/Genes/TCL1ID66.html |
| Genes | TCTA (T-cell leukemia translocation-associated gene) | Huret JL | http://atlasgeneticsoncology.org/Genes/TCTAID58.html |
| Genes | TCTA (T-cell leukemia translocation-associated gene) | Huret JL | http://atlasgeneticsoncology.org/Genes/TCTAID58.html |
| Genes | TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) | Hamelin R, Huret JL | http://atlasgeneticsoncology.org/Genes/P53ID88.html |
| Genes | TP53 (Tumour protein p53 (Li-Fraumeni syndrome)) | Hamelin R, Huret JL | http://atlasgeneticsoncology.org/Genes/P53ID88.html |
| Genes | TRIP11 (thyroid hormone receptor interactor 11) | Huret JL | http://atlasgeneticsoncology.org/Genes/CEV14ID96.html |
| Genes | ZBTB16 (zinc finger and BTB domain containing 16) | Viguié F | http://atlasgeneticsoncology.org/Genes/PLZFID37.html |
| Genes | ZMYM2 (fused in myeloproliferative disorders). | Huret JL, Leroux D | http://atlasgeneticsoncology.org/Genes/ZNF198ID114.html |
| Leukemias | 11q23 rearrangements (KMT2A) in leukaemia | Huret JL | http://atlasgeneticsoncology.org/Anomalies/11q23ID1030.html |
| Leukemias | 11q23 rearrangements (KMT2A) in therapy related leukaemias | Huret JL | http://atlasgeneticsoncology.org/Anomalies/11q23secondLeukID1131.html |
| Leukemias | 12p abnormalities in myeloid malignancies | Bilhou-Nabera C | http://atlasgeneticsoncology.org/Anomalies/12pmyeloID1032.html |
| Leukemias | 1q rearrangements in multiple myeloma | Brigaudeau C | http://atlasgeneticsoncology.org/Anomalies/1qMM2056ID2056.html |
| Leukemias | Acute basophilic leukemia | Dastugue N | http://atlasgeneticsoncology.org/Anomalies/LAbaso1124ID1124.html |
| Leukemias | B-cell prolymphocytic leukemia (B-PLL) (published in 1998) | Michaux L | http://atlasgeneticsoncology.org/Anomalies/BPLLID1860.html |
| Leukemias | Essential Thrombocythemia (ET) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/ETID1107.html |
| Leukemias | Mantle cell lymphoma | Huret JL | http://atlasgeneticsoncology.org/Anomalies/MantleCellID2062.html |
| Leukemias | Multiple myeloma (published in 2004) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/MMULID2038.html |
| Leukemias | Myelofibrosis with Myeloid Metaplasia (MMM) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/MyelofibID1102.html |
| Leukemias | Splenic lymphoma with villous lymphocytes (SLVL) in 2005 | Huret JL, Mossafa H | http://atlasgeneticsoncology.org/Anomalies/splenvillousID2063.html |
| Leukemias | Systemic mast cell disease (SMCD) | Larizza L, Beghini A | http://atlasgeneticsoncology.org/Anomalies/MastCellID2064.html |
| Leukemias | del(5q) in myeloid neoplasms | Charrin C | http://atlasgeneticsoncology.org/Anomalies/del5qID1092.html |
| Leukemias | del(6q) abnormalities in lymphoid malignancies | Brigaudeau C, Bilhou-Nabera C | http://atlasgeneticsoncology.org/Anomalies/del6qID1148.html |
| Leukemias | del(6q) in Multiple Myeloma | Brigaudeau C | http://atlasgeneticsoncology.org/Anomalies/del6qMMID2060.html |
| Leukemias | del(9q) solely | Viguié F | http://atlasgeneticsoncology.org/Anomalies/del9qID1021.html |
| Leukemias | der(1;7)(q10;p10) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0107ID1003.html |
| Leukemias | t(10;11)(p12;q21) PICALM/MLLT10 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1011bisID1067.html |
| Leukemias | t(11;14)(p13;q11) TRD/LMO2 | Bilhou-Nabera C | http://atlasgeneticsoncology.org/Anomalies/t1114ID1070.html |
| Leukemias | t(11;14)(q13;q32) IGH/CCND1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1114ID2021.html |
| Leukemias | t(11;14)(q13;q32) IGH/CCND1 in multiple myeloma | Huret JL, Laï JL | http://atlasgeneticsoncology.org/Anomalies/t1114MMID2054.html |
| Leukemias | t(11;17)(q13;q21) NUMA1/RARA | Viguié F | http://atlasgeneticsoncology.org/Anomalies/t1117ID1126.html |
| Leukemias | t(11;17)(q23;q21) ZBTB16/RARA | Viguié F | http://atlasgeneticsoncology.org/Anomalies/t1117ID1028.html |
| Leukemias | t(11;19)(q23;p13.3) KMT2A/MLLT1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1119ENLID1071.html |
| Leukemias | t(14;18)(q32;q21) IGH/BCL2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1418ID2006.html |
| Leukemias | t(15;17)(q24;q21) PML/RARA | Huret JL, Chomienne C | http://atlasgeneticsoncology.org/Anomalies/t1517ID1035.html |
| Leukemias | t(16;21)(p11;q22) FUS/ERG | Pérot C | http://atlasgeneticsoncology.org/Anomalies/t1621ID1037.html |
| Leukemias | t(16;21)(q24;q22) RUNX1/CBFA2T3 | Pérot C | http://atlasgeneticsoncology.org/Anomalies/t1621ID1123.html |
| Leukemias | t(1;11)(q21;q23) KMT2A/MLLT11 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t111ID1004.html |
| Leukemias | t(1;3)(p32;p21) TCTA/TAL1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1031108ID1108.html |
| Leukemias | t(1;5)(p32;q31) ?/TAL1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0105ID1141.html |
| Leukemias | t(1;7)(p32;q34) TRB/TAL1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0114ID1047.html |
| Leukemias | t(3;13)(q27;q14) LCP1/BCL6 | Huret JL and Laï JL | http://atlasgeneticsoncology.org/Anomalies/t0313ID2053.html |
| Leukemias | t(3;14)(q27;q32) IGH/BCL6 | Bastard C | http://atlasgeneticsoncology.org/Anomalies/t314ID2004.html |
| Leukemias | t(3;4)(q27;p13) RHOH/BCL6 | Daudignon A | http://atlasgeneticsoncology.org/Anomalies/t34ID2055.html |
| Leukemias | t(4;12)(q12;p13) CHIC2/ETV6 | Huret JL, Lafage-Pochitaloff M | http://atlasgeneticsoncology.org/Anomalies/t0412ID1010.html |
| Leukemias | t(4;14)(p16;q32) IGH/FGFR3 and WHSC1 | Huret JL, Bonaventure J | http://atlasgeneticsoncology.org/Anomalies/t04142059ID2059.html |
| Leukemias | t(5;12)(q33;p13) ETV6/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0512ID1012.html |
| Leukemias | t(5;14)(q33;q32) PDGFRB/TRIP11 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0514ANLID1118.html |
| Leukemias | t(5;7)(q33;q11) HIP1/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t057ID1062.html |
| Leukemias | t(6;9)(p22;q34) DEK/NUP214 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0609ID1014.html |
| Leukemias | t(8;13)(p11;q12) ZMYM2/FGFR1 | Huret JL, Leroux D, Bernheim A | http://atlasgeneticsoncology.org/Anomalies/t813ID1094.html |
| Leukemias | t(8;16)(p11;p13) KAT6A/CREBBP | Pérot C, Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0816ID1018.html |
| Leukemias | t(9;12)(p24;p13) ETV6/JAK2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Bone and Soft Tissue: Ewing sarcoma | Couturier J | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Bone: Chordoma | Miozzo M | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Colon: Colorectal adenocarcinoma | Hamelin R | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Kidney: Papillary renal cell carcinoma | Couturier J | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Nervous system: Embryonal tumors: Neuroblastoma | Couturier J, Satgé D | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Soft Tissues: Ewing's tumors/Primitive neurectodermal tumor with t(16;21)(p11;q22) FUS/ERG | Pérot C | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Soft Tissues: Rhabdomyosarcoma | Couturier J | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Solid Tumors | Testis: Germ cell tumors | Desangles F, Camparo P | http://atlasgeneticsoncology.org/Anomalies/1122t0912ID1122.html |
| Cancer-Prones | APC-associated polyposis conditions | Olschwang S | http://atlasgeneticsoncology.org/Kprones/adenom_polID10012.html |
| Cancer-Prones | Ataxia telangiectasia (A-T) | Huret JL | http://atlasgeneticsoncology.org/Kprones/ataxiaID10003.html |
| Cancer-Prones | Bannayan-Riley-Ruvalcaba syndrome | Huret JL | http://atlasgeneticsoncology.org/Kprones/BannayanID10044.html |
| Cancer-Prones | Bloom syndrome | Huret JL | http://atlasgeneticsoncology.org/Kprones/BLOID10002.html |
| Cancer-Prones | Dubowitz syndrome | Huret JL, Léonard C | http://atlasgeneticsoncology.org/Kprones/DUBID10016.html |
| Cancer-Prones | Epidermodysplasia verruciformis | Viguié C | http://atlasgeneticsoncology.org/Kprones/epiderm_verID10019.html |
| Cancer-Prones | Familial /sporadic gastrointestinal stromal tumors (GISTs) | Larizza L, Beghini A | http://atlasgeneticsoncology.org/Kprones/GastroISTID10029.html |
| Cancer-Prones | Fanconi anemia | Huret JL | http://atlasgeneticsoncology.org/Kprones/FAID10001.html |
| Cancer-Prones | Neurofibromatosis type 2 (NF2) | Huret JL | http://atlasgeneticsoncology.org/Kprones/NF2KprID10007.html |
| Cancer-Prones | Nijmegen breakage syndrome | Couturier J | http://atlasgeneticsoncology.org/Kprones/NijmegenID10020.html |
| Cancer-Prones | Piebaldism | Larizza L, Beghini A | http://atlasgeneticsoncology.org/Kprones/piebaldID10030.html |
| Cancer-Prones | Retinoblastoma (hereditary predisposition) | Lohmann DR | http://atlasgeneticsoncology.org/Kprones/RbKprID10031.html |
| Cancer-Prones | Rothmund-Thomson syndrome (RTS) | Larizza L | http://atlasgeneticsoncology.org/Kprones/RothmundID10021.html |
| Cancer-Prones | Von Hippel-Lindau | Capodano AM | http://atlasgeneticsoncology.org/Kprones/VHLKprID10010.html |
